CRISPR/Cas9-mediated ApoE-/- and LDLR-/- double gene knockout in pigs elevates serum LDL-C and TC levels
Metrics: PDF 1933 views | HTML 3200 views | ?
Lei Huang1,3, Zaidong Hua2, Hongwei Xiao2, Ying Cheng1, Kui Xu1, Qian Gao1, Ying Xia1, Yang Liu1, Xue Zhang1, Xinming Zheng2, Yulian Mu1 and Kui Li1
1State Key Laboratory of Animal Nutrition, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, China
2Hubei Key Laboratory of Animal Embryo Engineering and Molecular Breeding, Institute of Animal Science and Veterinary Medicine, Hubei Academy of Agricultural Science, Wuhan 430064, China
3Animal Functional Genomics Group, Agricultural Genomes Institute at Shenzhen, Chinese Academy of Agricultural Sciences, Shenzhen 518120, China
Yulian Mu, email: [email protected]
Keywords: cardiovascular disease, dyslipidemia, animal model, multiple-gene knockout, gene editing
Received: September 06, 2016 Accepted: March 28, 2017 Published: April 17, 2017
The traditional method to establish a cardiovascular disease model induced by high fat and high cholesterol diets is time consuming and laborious and may not be appropriate in all circumstances. A suitable pig model to study metabolic disorders and subsequent atherosclerosis is not currently available. For this purpose, we applied the CRISPR/Cas9 system to Bama minipigs, targeting apolipoprotein E (ApoE) and low density lipoprotein receptor (LDLR) gene simultaneously. Six biallelic knockout pigs of these two genes were obtained successfully in a single step. No off-target incidents or mosaic mutations were detected by an unbiased analysis. Serum biochemical analyses of gene-modified piglets showed that the levels of low density lipoprotein choleserol (LDL-C), total cholesterol (TC) and apolipoprotein B (APOB) were elevated significantly. This model should prove valuable for the study of human cardiovascular disease and related translational research.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.